SerenityShares Impact ETF ICAN 深 沪
等待开盘 03-26 09:30:00 美东时间
28.485
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 28.485
- 总市值 427.00万
- 52周最高 29.8814
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 24.127
- 委 比 0.00%
- 总股本 14.99万
- 历史最高 29.8814
- 量 比 0
- 振 幅 0.00%
- 历史最低 24.127
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-American Express Launches New Graphite Business Cash Unlimited Card
BRIEF-American Express Launches New Graphite Business Cash Unlimited Card March 25 (Reuters) - American Express Co AXP.N : AMERICAN EXPRESS: LAUNCHES NEW GRAPHITE BUSINESS CASH UNLIMITED CARD AMERICAN EXPRESS: BUSINESS MEMBERSHIP TO EXPAND WITH EIGHT NEW PRODUCTS, BENEFITS, AI-POWERED CAPABILITIES F
03-25 19:00
Bitmine Immersion Technologies Announces As Of March 22, The Company's Crypto Holdings Are Comprised Of 4,660,903 ETH, 196 Bitcoin, $200M Stake In Beast Industries, $95M Stake In Eightco Holdings And Total Cash Of $1.1B
(NYSE AMERICAN: BMNR) Bitmine Immersion Technologies, Inc. ("Bitmine" or the "Company") a Bitcoin and Ethereum Network company with a focus on the accumulation of crypto for long term investment, today announced
03-23 20:41
BRIEF-Eli Lilly's Retatrutide Showed Significant Reductions In A1C & Weight In TRANSCEND-T2D-1 Trial
BRIEF-Eli Lilly's Retatrutide Showed Significant Reductions In A1C & Weight In TRANSCEND-T2D-1 Trial March 19 (Reuters) - Eli Lilly and Co LLY.N : ELI LILLY: RETATRUTIDE SHOWED SIGNIFICANT REDUCTIONS IN A1C & WEIGHT IN FIRST PHASE 3 TRIAL FOR TYPE 2 DIABETES TREATMENT ELI LILLY: RETATRUTIDE LOWERED
03-19 18:45
BRIEF-S&P Says Honda Motor Downgraded To 'BBB+' On Earnings Downturn; Outlook Stable
BRIEF-S&P Says Honda Motor Downgraded To 'BBB+' On Earnings Downturn; Outlook Stable March 19 (Reuters) - S&P: S&P: HONDA MOTOR DOWNGRADED TO 'BBB+' ON EARNINGS DOWNTURN; OUTLOOK STABLE S&P: HONDA MOTOR'S PERFORMANCE WILL DETERIORATE SIGNIFICANTLY IN NEXT COUPLE OF YEARS ON EV-RELATED LOSSES AND TAK
03-19 14:22
BRIEF-Intuit Significantly Scales Share Repurchase Program Founder & Executive Leadership Team Terminate Pre-Scheduled Stock Sales
BRIEF-Intuit Significantly Scales Share Repurchase Program Founder & Executive Leadership Team Terminate Pre-Scheduled Stock Sales March 16 (Reuters) - Intuit Inc INTU.O : INTUIT: SIGNIFICANTLY SCALES SHARE REPURCHASE PROGRAM; FOUNDER & EXECUTIVE LEADERSHIP TEAM TERMINATE PRE-SCHEDULED STOCK SALES I
03-16 19:50
BRIEF-Public Storage To Acquire National Storage Affiliates, Creating Significant Value For All Stakeholders
BRIEF-Public Storage To Acquire National Storage Affiliates, Creating Significant Value For All Stakeholders March 16 (Reuters) - Public Storage PSA.N : PUBLIC STORAGE TO ACQUIRE NATIONAL STORAGE AFFILIATES, CREATING SIGNIFICANT VALUE FOR ALL STAKEHOLDERS PUBLIC STORAGE: ALL-STOCK TRANSACTION WITH A
03-16 19:32
BRIEF-Reliance Subsidiary AMI Metals Awarded Significant Government Infrastructure And Defense Projects
BRIEF-Reliance Subsidiary AMI Metals Awarded Significant Government Infrastructure And Defense Projects March 10 (Reuters) - Reliance Inc RS.N : RELIANCE, INC. SUBSIDIARY AMI METALS, INC. AWARDED SIGNIFICANT GOVERNMENT INFRASTRUCTURE AND DEFENSE PROJECTS RELIANCE INC - AMI METALS AWARDED MULTI-YEAR
03-10 18:53
BRIEF-Bristol Myers Reports Positive Phase 3 Results For Oral Mezigdomide In Relapsed Myeloma
BRIEF-Bristol Myers Reports Positive Phase 3 Results For Oral Mezigdomide In Relapsed Myeloma March 9 (Reuters) - Bristol-Myers Squibb Co BMY.N : BRISTOL MYERS SQUIBB ANNOUNCES POSITIVE PHASE 3 RESULTS FROM THE SUCCESSOR-2 STUDY OF ORAL MEZIGDOMIDE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA BRISTOL-
03-09 19:14
BRIEF-Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis
BRIEF-Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis March 9 (Reuters) - Pfizer Inc PFE.N : PFIZER’S PHASE 2 STUDY OF TRISPECIFIC ANTIBODY POSITIVE IN MODERATE TO SEVERE ATOPIC DERMATITIS PFIZER - PHASE 2 STUDY MET PRIMARY ENDPOINT WITH STATISTICALLY
03-09 19:11
BRIEF-Mobix Labs Secures Significant U.S. Navy Tomahawk Missile Component Order As Production Accelerates
BRIEF-Mobix Labs Secures Significant U.S. Navy Tomahawk Missile Component Order As Production Accelerates March 3 (Reuters) - MOBIX LABS, INC. MOBX.O : MOBIX LABS SECURES SIGNIFICANT U.S. NAVY TOMAHAWK MISSILE COMPONENT ORDER AS PRODUCTION ACCELERATES Source text: ID:nBw1W0q0Ca Further company cover
03-03 20:35
